Biomarker test can measure risk, severity of heart attack

01/2/2012 | International Business Times

A test of the level of muscle tissue protein troponin I could make heart attack diagnosis faster and more accurate, according to a study in the Journal of the American Medical Association. German researchers found that patients with higher levels of troponin appeared to be at increased risk of having a heart attack while changes in troponin levels can help diagnose and determine the severity of myocardial infarction.

View Full Article in:

International Business Times

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA